Liquid Biopsy to Inform Targeted Tx of Colorectal Cancer

In this video, Dr. Heinz-Josef Lenz outlines the many advantages that development of liquid biopsy is affording cancer patients.

Related Content:

Colorectal Cancer

Identifying Use of ctDNA Across Tumor Types

Understanding the Mechanisms and Use of ctDNA and MRD Testing

FDA Lifts Clinical Hold on Trial Assessing CYAD-101 Plus Pembrolizumab and FOLFOX in Advanced CRC